Consultant / Head of Microbiology Research & Development / Infection Lead of Leeds NIHR Diagnostic Technologies Medical Technology and In Vitro Diagnostic Co-operative

Professor of Medical Microbiology
Sir Edward Brotherton Chair of Bacteriology
University of Leeds

Consultant / Head of Microbiology Research & Development /
Infection Lead of Leeds NIHR Diagnostic Technologies Medical Technology and In Vitro Diagnostic Co-operative
Leeds Teaching Hospitals NHS Trust

Lead on C. difficile infection
Public Health England

Medical Advisor to National Infection Prevention & Control Lead
NHS Improvement

Prof. Mark Wilcox serves in multiple advisory roles including to UK SAGE (COVID-19), as a medical advisor to the National Infection Prevention & Control Lead (NHSImprovement/England, the Medical Research Council’s Infection and Immunity Panel, as Chair of PHE’s Rapid Review Panel (reviews the utility of infection prevention & control products for the NHS) and member of the UK NHS Antimicrobial Resistance Programme Board.

Prof Wilcox leads a Healthcare Associated Infection Research Group at the University of Leeds (http://medhealth.leeds.ac.uk/hcai), comprising ~30 doctors, scientists and nurses. Projects include multiple aspects of Clostridium difficile infection, diagnostics, antibiotic resistance and the gut microbiome, infection prevention and control interventions, and the clinical development of new antimicrobial agents.